News and Events


American Society of Hematology (ASH)

December 6-10, 2019

American Society of Clinical Oncology (ASCO)

May 29 - June 2, 2020


John Belcher, PhD, received a grant from the National Heart, Lung, And Blood Institute of the National Institutes of Health. With the support of this grant, Dr. Belcher and his research team will investigate the potential use of circulating endothelial cells (CECs) and endothelial-derived microvesicles (EMV) as biomarkers of response to gene therapy for sickle cell disease. CECs and EMVs are present at low levels in healthy subjects, but are elevated in a variety of systemic inflammatory diseases, including sickle cell disease and are therefore ideal biomarkers for diagnosis and prognosis of systemic inflammatory disorders. By standardizing and validating CECs and EMVs as biomarkers of disease modification in sickle cell disease, Dr. Belcher’s investigations will provide a defined scientific methodology to track changes in the vascular endothelium after curative gene therapy for sickle cell disease. Please join us in congratulating Dr. Belcher. (September 2019)

Marshall Mazepa, MD, received a grant from the Answering TTP Foundation, a non-profit organization committed to supporting research to improve the prognosis of patients with thrombotic thrombocytopenic purpura (TTP). With the support of a grant from Answering TTP, Dr. Mazepa will investigate strategies to improve the neuropsychologic complications of acquired TTP. Please join us in congratulating Dr. Mazepa on the receipt of this grant. (September 2019)

Read More